Natco Pharma Limited

Report DateResearch houseDescriptionRecoAt PriceTarget PriceUpSide
/DownSide
Download
13-Aug-21 Isec Sequential domestic recovery amid Covid sales… Buy 1021 1040 1.86
13-Aug-20 Isec Stable quarter; next growth phase hinges on new ventures Buy 817 950 16.28
19-Jun-20 Isec Subdued quarter; next growth phase hinges on new ventures Buy 621 740 19.16
6-Nov-17 Nirmal Bang Sec In A Sweet Spot Buy 953 1102 15.63
5-Oct-17 Nirmal Bang Sec Copaxone Generic Approval To Fortify Base Business Earnings Buy 952 1102 15.76

Upcoming Events and Recent Updates

10-Apr-24
Post ITs (Interesting Article) - Natco Pharma gets warning letter from USFDA for Telangana plant  ( updated on Apr 10 2024)

Analyst Calls / Meets


Management Interviews

03-May-21 Rajeev Nannapan..  
03-May-21 Rajeev Nannapan..  
18-Nov-13 Bhaskar Narayan..  
29-Jul-13 Bhaskar Narayan..  
01-Apr-13 Bhaskar Narayan..  

Investor Presentations

15-Feb-24 Investor/Anal...
15-Nov-23 Investor/Anal...
10-Aug-23 Investor/Anal...
30-May-23 Investor/Anal...
09-Feb-23 Investor/Anal...

Annual Reports
Source: Reportjunction.com

2022-23  
2021-22  
2020-21  
2019-20  
2018-19  

Research Showcase

13-Aug-21
Isec - Quarter ..
Download
13-Aug-20
Isec - Quarter ..
Download
19-Jun-20
Isec - Quarter ..
Download
06-Nov-17
Nirmal Bang Sec..
Download
05-Oct-17
Nirmal Bang Sec..
Download

Results

15-Feb-24 Results
15-Nov-23 Results
10-Aug-23 Results
09-Feb-23 Results
10-Nov-22 Results

AGM/EGM/Board Meetings

12-Nov-19 - Quarterly Results & In..
05-Sep-19 - AGM
09-Aug-19 - Quarterly Results & In..
27-May-19 - Audited Results & Inte..
12-Feb-19 - Quarterly Results & In..

Press Release

15-Nov-23 Press Release
10-Aug-23 Press Release
17-Jun-21 Press Release
09-Mar-21 Press Release
26-Feb-21 Press Release

 

Archived Documents

No Archieved Transcript.